MC2R and Aarskog-Scott syndrome, X-linked: Inactivating mutations in the ACTH receptor/MC2R in patients with FGD were first described in 1993.2,3 Since then many other mutations have been identified which account for approximately 25% of cases of FGD (reviewed in Ref.